Loading...

Lee Jay

Title(s)Surgical Director, Thoracic Oncology Program
Phone(310) 794-7335
vCardDownload vCard
    Other Positions
    Title(s)Surgical Director, UCLA Center for Esophageal Disorders

    Title(s)Surgical Director Thoracic Oncology Program, Lung Cancer Program

    Title(s)Associate Professor, Surgery

    Title(s)Chief, Thoracic Surgery


    Collapse Research 
    Collapse Research Activities and Funding
    Gene Modified Dendritic Cell Therapy in Lung Cancer
    NIH/NCI K23CA131577Aug 1, 2009 - Jul 31, 2014
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Shirali AS, Grotts J, Elashoff D, Barjaktarevic I, Melamed KH, Van Hassel J, Cameron RB, Lee JM, Yanagawa J. Predictors of Outcomes After Thoracic Surgery in Orthotopic Liver Transplant Recipients with Pleural Disease. Semin Thorac Cardiovasc Surg. 2019 Feb 04. PMID: 30731193.
      View in: PubMed
    2. Savitsky E, Oh SS, Lee JM. The Evolving Epidemiology and Management of Spontaneous Pneumothorax. JAMA. 2018 10 09; 320(14):1441-1443. PMID: 30304415.
      View in: PubMed
    3. Polverari G, Ceci F, Allen-Auerbach M, Gupta P, Fishbein MC, Reiter RE, Lee JM, Hope TA, Carroll RM, Czernin J, Calais J. Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68Ga-PSMA-11 PET/CT. Clin Genitourin Cancer. 2018 Sep 07. PMID: 30293922.
      View in: PubMed
    4. Sandler KA, Abtin F, Suh R, Cook RR, Felix C, Lee JM, Garon EB, Wu J, Luterstein EM, Agazaryan N, Tenn SE, Lee C, Steinberg ML, Lee P. A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung Tumors. Int J Radiat Oncol Biol Phys. 2018 Jul 01; 101(3):564-573. PMID: 29893274.
      View in: PubMed
    5. Revels SL, Lee JM. Anti-angiogenic therapy in nonsquamous non-small cell lung cancer (NSCLC) with tyrosine kinase inhibition (TKI) that targets the VEGF receptor (VEGFR): perspective on phase III clinical trials. J Thorac Dis. 2018 Feb; 10(2):617-620. PMID: 29607123.
      View in: PubMed
    6. Khakpour H, Shemin RJ, Lee JM, Buch E, Boyle NG, Shivkumar K, Bradfield JS. Atrioesophageal Fistula After Atrial Fibrillation Ablation: A single center series. J Atr Fibrillation. 2017 Oct-Nov; 10(3):1654. PMID: 29250244.
      View in: PubMed
    7. Ajijola OA, Hoover DB, Simerly TM, Brown TC, Yanagawa J, Biniwale RM, Lee JM, Sadeghi A, Khanlou N, Ardell JL, Shivkumar K. Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm. JCI Insight. 2017 Sep 21; 2(18). PMID: 28931760.
      View in: PubMed
    8. Lee JM, Lee MH, Garon E, Goldman JW, Salehi-Rad R, Baratelli FE, Schaue D, Wang G, Rosen F, Yanagawa J, Walser TC, Lin Y, Park SJ, Adams S, Marincola FM, Tumeh PC, Abtin F, Suh R, Reckamp KL, Lee G, Wallace WD, Lee S, Zeng G, Elashoff DA, Sharma S, Dubinett SM. Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration. Clin Cancer Res. 2017 Aug 15; 23(16):4556-4568. PMID: 28468947.
      View in: PubMed
    9. Toste PA, Lee JM. Limited resection versus lobectomy in early-stage non-small cell lung cancer. J Thorac Dis. 2016 Nov; 8(11):E1511-E1513. PMID: 28066646.
      View in: PubMed
    10. Onugha OI, Lee JM. Surgical Treatment of Lung Cancer. Cancer Treat Res. 2016; 170:77-104. PMID: 27535390.
      View in: PubMed
    11. Fishbein GA, Grimes BS, Xian RR, Lee JM, Barjaktarevic I, Xu H. Primary salivary duct carcinoma of the lung, mucin-rich variant. Hum Pathol. 2016 Jan; 47(1):150-6. PMID: 26527521.
      View in: PubMed
    12. Kishan AU, Cameron RB, Wang PC, Alexander S, Qi SX, Low DA, Kupelian PA, Steinberg ML, Lee JM, Selch MT, Lee P. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):366-73. PMID: 26432677.
      View in: PubMed
    13. Zhu LX, Davoodi M, Srivastava MK, Kachroo P, Lee JM, St John M, Harris-White M, Huang M, Strieter RM, Dubinett S, Sharma S. GITR agonist enhances vaccination responses in lung cancer. Oncoimmunology. 2015 Apr; 4(4):e992237. PMID: 26137407.
      View in: PubMed
    14. Lee MH, Kachroo P, Pagano PC, Yanagawa J, Wang G, Walser TC, Krysan K, Sharma S, John MS, Dubinett SM, Lee JM. Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway. J Cancer Sci Ther. 2014 Nov; 6(11):468-477. PMID: 26523208.
      View in: PubMed
    15. Lin AY, Kotova S, Yanagawa J, Elbuluk O, Wang G, Kar N, Elashoff D, Grogan T, Cameron RB, Singh A, Chmielowski B, Federman N, Nelson SD, Lee P, Eilber FC, Lee JM. Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):85-92. PMID: 25312228.
      View in: PubMed
    16. Rwigema JC, Chen AM, Wang PC, Lee JM, Garon E, Lee P. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy. Clin Lung Cancer. 2014 Jul; 15(4):287-93. PMID: 24594401.
      View in: PubMed
    17. Kachroo P, Lee MH, Zhang L, Baratelli F, Lee G, Srivastava MK, Wang G, Walser TC, Krysan K, Sharma S, Dubinett SM, Lee JM. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res. 2013 Nov 25; 32:97. PMID: 24274066; PMCID: PMC3906956.
    18. Mehta N, Selch M, Wang PC, Federman N, Lee JM, Eilber FC, Chmielowski B, Agazaryan N, Steinberg M, Lee P. Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma. Sarcoma. 2013; 2013:360214. PMID: 24198717; PMCID: PMC3807836.
    19. Krysan K, Cui X, Gardner BK, Reckamp KL, Wang X, Hong L, Walser TC, Rodriguez NL, Pagano PC, Garon EB, Brothers JF, Elashoff D, Lee JM, Spira AE, Sharma S, Fishbein MC, Dubinett SM. Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer. Am J Transl Res. 2013; 5(5):481-96. PMID: 23977408; PMCID: PMC3745436.
    20. Sharma S, Zhu L, Srivastava MK, Harris-White M, Huang M, Lee JM, Rosen F, Lee G, Wang G, Kickhoefer V, Rome LH, Baratelli F, St John M, Reckamp K, Chul-Yang S, Hillinger S, Strieter R, Dubinett S. CCL21 Chemokine Therapy for Lung Cancer. Int Trends Immun. 2013 Jan; 1(1):10-15. PMID: 25264541.
      View in: PubMed
    21. Srivastava MK, Zhu L, Harris-White M, Huang M, St John M, Lee JM, Salgia R, Cameron RB, Strieter R, Dubinett S, Sharma S. Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer. Immunotargets Ther. 2012 Oct 01; 2012(1):7-12. PMID: 24791250.
      View in: PubMed
    22. Srivastava MK, Zhu L, Harris-White M, Kar UK, Kar U, Huang M, Johnson MF, Lee JM, Elashoff D, Strieter R, Dubinett S, Sharma S. Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One. 2012; 7(7):e40677. PMID: 22815789; PMCID: PMC3398024.
    23. Zhang L, Xiao H, Zhou H, Santiago S, Lee JM, Garon EB, Yang J, Brinkmann O, Yan X, Akin D, Chia D, Elashoff D, Park NH, Wong DTW. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell Mol Life Sci. 2012 Oct; 69(19):3341-3350. PMID: 22689099; PMCID: PMC4121486.
    24. Kachroo P, Pak PS, Sandha HS, Lee C, Elashoff D, Nelson SD, Chmielowski B, Selch MT, Cameron RB, Holmes EC, Eilber FC, Lee JM. Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomas. J Thorac Oncol. 2012 Mar; 7(3):552-8. PMID: 22307013.
      View in: PubMed
    25. Srivastava MK, Andersson Å, Zhu L, Harris-White M, Lee JM, Dubinett S, Sharma S. Myeloid suppressor cells and immune modulation in lung cancer. Immunotherapy. 2012 Mar; 4(3):291-304. PMID: 22401635; PMCID: PMC3324285.
    26. Kachroo P, Pak PS, Sandha HS, Nelson SD, Seeger LL, Cameron RB, Eilber FC, Lee JM. Chest wall sarcomas are accurately diagnosed by image-guided core needle biopsy. J Thorac Oncol. 2012 Jan; 7(1):151-6. PMID: 21900839.
      View in: PubMed
    27. Xiao H, Zhang L, Zhou H, Lee JM, Garon EB, Wong DT. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics. 2012 Feb; 11(2):M111.012112. PMID: 22096114; PMCID: PMC3277759.
    28. Pak PS, Yanagawa J, Abtin F, Wallace WD, Holmes EC, Lee JM. Surgical management of endobronchial solitary fibrous tumors. Ann Thorac Surg. 2010 Aug; 90(2):659-61. PMID: 20667378; PMCID: PMC3158992.
    29. Dubinett SM, Lee JM, Sharma S, Mulé JJ. Chemokines: can effector cells be redirected to the site of the tumor? Cancer J. 2010 Jul-Aug; 16(4):325-35. PMID: 20693843; PMCID: PMC3076643.
    30. Yanagawa J, Abtin F, Lai CK, Yeh M, Britten CD, Martinez D, Crisera CA, Holmes EC, Lee JM. Resection of thyroid cancer metastases to the sternum. J Thorac Oncol. 2009 Aug; 4(8):1022-5. PMID: 19633476.
      View in: PubMed
    31. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S, Dubinett SM. Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc. 2008 Dec 01; 5(8):811-5. PMID: 19017734; PMCID: PMC4080902.
    32. Lee JM, Pou K, Sadow PM, Chen H, Hu B, Hewison M, Adams JS, Sugarbaker DJ, Fisher ND. Vitamin D-mediated hypercalcemia and Cushing syndrome as manifestations of malignant pleural mesothelioma. Endocr Pract. 2008 Nov; 14(8):1011-6. PMID: 19095601.
      View in: PubMed
    33. Baratelli F, Takedatsu H, Hazra S, Peebles K, Luo J, Kurimoto PS, Zeng G, Batra RK, Sharma S, Dubinett SM, Lee JM. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer. J Transl Med. 2008 Jul 22; 6:38. PMID: 18644162; PMCID: PMC2507704.
    34. Lee JM, Yanagawa J, Peebles KA, Sharma S, Mao JT, Dubinett SM. Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit Rev Oncol Hematol. 2008 Jun; 66(3):208-17. PMID: 18304833; PMCID: PMC2483429.
    35. Krysan K, Lee JM, Dohadwala M, Gardner BK, Reckamp KL, Garon E, St John M, Sharma S, Dubinett SM. Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance. J Thorac Oncol. 2008 Feb; 3(2):107-10. PMID: 18303428.
      View in: PubMed
    36. Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev Anticancer Ther. 2007 Oct; 7(10):1405-21. PMID: 17944566.
      View in: PubMed
    37. Lee JM, Mao JT, Krysan K, Dubinett SM. Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC. Future Oncol. 2007 Apr; 3(2):149-53. PMID: 17381414.
      View in: PubMed